Regional Distribution of Mitochondrial Dysfunction and Apoptotic Remodeling in Pacing-Induced Heart Failure

Journal of Cardiac Failure

Volumn 15, Issue 8, 2009, Pages 700-708

  Marín García, José ^a   Goldenthal, Michael J ^a   Damle, Shirish ^a   Pi, Yeqing ^a   Moe, Gordon W ^b  

^a Molec Cardiol/Neuromuscular Inst   (United States)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

apoptosis; cardiac failure; Energy metabolism; mitochondria

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE 3; CELL NUCLEUS DNA; COMPLEX V; CYTOCHROME B; MITOCHONDRIAL CREATINE KINASE; MITOCHONDRIAL DNA; MITOCHONDRIAL ENZYME; P21 ACTIVATED KINASE; PROTEIN P53; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COMPLEX I DEFICIENCY; COMPLEX III DEFICIENCY; COMPLEX V DEFICIENCY; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOG; ENERGY METABOLISM; ENZYME DEFECT; HEART FAILURE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; HEART PACING; IMMUNOBLOTTING; MITOCHONDRIAL GENE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CARDIAC PACING, ARTIFICIAL; DISEASE MODELS, ANIMAL; DOGS; HEART FAILURE; MITOCHONDRIA, HEART; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING;

EID: 70349322483     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.04.010     Document Type: Article

References (44)

1. Moe G.W., and Armstrong P.W. Pacing-induced heart failure: a model to study the mechanism of disease progression and novel therapy in heart failure. Cardiovasc Res 42 (1999) 591-599
2. Kajstura J., Zhang X., Liu Y., Szoke E., Cheng W., Olivetti G., et al. The cellular basis of pacing-induced dilated cardiomyopathy: myocyte cell loss and myocyte cellular reactive hypertrophy. Circulation 92 (1995) 2306-2317
3. Bradham W.S., Moe G., Wendt K.A., Scott A.A., Konig A., Romanova M., et al. TNF-a and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling. Am J Physiol Heart Circ Physiol 282 (2002) H1288-H1295
4. Khan A., Moe G.W., Nili N., Rezaei E., Eskandarian M., Butany J., et al. The cardiac atria are chambers of active remodeling and dynamic collagen turnover during evolving heart failure. J Am Coll Cardiol 43 (2004) 68-76
5. Hanna N., Cardin S., Leung T.K., and Nattel S. Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing induced congestive heart failure. Cardiovasc Res 63 (2004) 236-244
6. Heinke M.Y., Yao M., Chang D., Einstein R., and dos Remedios C.G. Apoptosis of ventricular and atrial myocytes from pacing-induced canine heart failure. Cardiovasc Res 49 (2001) 127-134
7. Cha T.J., Ehrlich J.R., Zhang L., Shi Y.F., Tardif J.C., Leung T.K., et al. Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure. Circulation 109 (2004) 412-418
8. Marin-Garcia J., Goldenthal J.M., and Moe G.W. Abnormal cardiac and skeletal muscle mitochondrial function in pacing induced cardiac failure. Cardiovasc Res 52 (2001) 103-110
9. Cha Y.M., Dzeja P.P., Shen W.K., Jahangir A., Hart C.Y., Terzic A., et al. Failing atrial myocardium: energetic deficits accompany structural remodeling and electrical instability. Am J Physiol Heart Circ Physiol 284 (2003) H1313-H1320
10. Osorio J.C., Stanley W.C., Linke A., Castellari M., Diep Q.N., Panchal A.R., et al. Impaired myocardial fatty oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure. Circulation 106 (2002) 606-612
11. Ide T., Tsutsui H., Kinugawa S., Utsumi H., Kang D., Hattori N., et al. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res 85 (1999) 357-363
12. Ananthakrishnan R., Moe G.W., Goldenthal M.J., and Marín-García J. Akt signaling pathway in pacing-induced heart failure. Mol Cell Biochem 268 (2005) 103-110
13. Chandel N.S., McClintock D.S., Feliciano C.E., Wood T.M., Melendez J.A., Rodriguez A.M., et al. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1 during hypoxia: a mechanism of O2 sensing. J Biol Chem 275 (2000) 25130-25138
14. Ide T., Tsutsui H., Kinugawa S., Suematsu N., Hayashidani S., Ichikawa K., et al. Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ Res 86 (2000) 152-157
15. Moe G.W., Marin-Garcia J., Konig A., Goldenthal M., Lu X., and Feng Q. In vivo TNF-alpha inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure. Am J Physiol Heart Circ Physiol 287 (2004) H1813-H1820
16. Cesselli D., Jakoniuk I., Barlucchi L., Beltrami A.P., Hintze T.H., Nadal-Ginard B., et al. Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res 89 (2001) 279-286
17. Nakamura R., Egashira K., Machida Y., Hayashidani S., Takeya M., Utsumi H., et al. Probucol attenuates left ventricular dysfunction and remodeling in tachycardia-induced heart failure: roles of oxidative stress and inflammation. Circulation 106 (2002) 362-367
18. Palmer J.W., Tandler B., and Hoppel C.L. Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle. J Biol Chem 252 (1977) 8731-8739
19. Lesnefsky E.J., Tandler B., Ye J., Slabe T.J., Turkaly J., and Hoppel C.L. Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria. Am J Physiol Heart Circ Physiol 273 (1997) H1544-H1554
20. Luo X.P., Yazdanpanah M., Bhooi N., et al. Determination of aldehydes and other lipid peroxidation products in biological samples by gas chromatography-mass spectroscopy. Anal Chem 228 (1995) 294-298
21. Liu Y., Cigola E., Cheng W., Kajstura J., Olivetti G., Hintze T.H., and Anversa P. Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab Invest 73 (1995) 771-787
22. Kajstura J., Zhang X., Liu Y., Szoke E., Cheng W., Olivetti G., Hintze T.H., and Anversa P. The cellular basis of pacing-induced dilated cardiomyopathy. Myocyte cell loss and myocyte cellular reactive hypertrophy. Circulation 92 (1995) 2306-2317
23. Shizukuda Y., Buttrick P.M., Geenen D.L., Borczuk A.C., Kitsis R.N., and Sonnenblick E.H. Adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am J Physiol 275 (1998) H961-H968
24. Moe G.W., Naik G., Konig A., Lu X., and Feng Q. Early and persistent activation of myocardial apoptosis, bax and caspases: insights into mechanisms of progression of heart failure. Pathophysiology 8 (2002) 183-192
25. Leri A., Liu Y., Malhotra A., Li Q., Stiegler P., Claudio P.P., et al. Pacing-induced heart failure in dogs enhances the expression of p53 and p53-dependent genes in ventricular myocytes. Circulation 97 (1998) 194-203
26. Hoppel C.L., Moghaddas S., and Lesnefsky E.J. Interfibrillar cardiac mitochondrial complex III defects in the aging rat heart. Biogerontology 3 (2002) 41-44
27. Fannin S.W., Lesnefsky E.J., Slabe T.J., Hassan M.O., and Hoppel C.L. Aging selectively decreases oxidative capacity in rat heart interfibrillar mitochondria. Arch Biochem Biophys 372 (1999) 399-407
28. Lesnefsky E.J., Gudz T.I., Moghaddas S., Migita C.T., Ikeda-Saito M., Turkaly P.J., et al. Aging decreases electron transport complex III activity in heart interfibrillar mitochondria by alteration of the cytochrome c binding site. J Mol Cell Cardiol 33 (2001) 37-47
29. Cha Y., Dzeja P., Redfield M.R., Shen W.K., and Terzic A. Bioenergetic protection of failing atrial and ventricular myocardium by vasopeptidase inhibitor omapatrilat. Am J Physiol Heart Circ Physiol 290 (2006) H1686-H1692
30. Heinke M.Y., Wheeler C.H., Yan J.X., Amin V., Chang D., Einstein R., et al. Changes in myocardial protein expression in pacing-induced canine heart failure. Electrophoresis 20 (1999) 2086-2093
31. Gao Z., Xu H., DiSilvestre D., Halperin V.L., Tunin R., Tian Y., et al. Transcriptomic profiling of the canine tachycardia-induced heart failure model: global comparison to human and murine heart failure. J Mol Cell Cardiol 40 (2006) 76-86
32. Russell L.K., Mansfield C.M., Lehman J.J., Kovacs A., Courtois M., Saffitz J.E., et al. Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner. Circ Res 94 (2004) 525-533
33. Arany Z., He H., Lin J., Hoyer K., Handschin C., Toka O., et al. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab 1 (2005) 259-271
34. Finck B.N., and Kelly D.P. Peroxisome proliferator-activated receptor {gamma} coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease. Circulation 115 (2007) 2540-2548
35. Long X., Boluyt M.O., Hipolito M.L., Llundberg M.S., Zheng J.S., O'Neill L., et al. p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. J Clin Invest 99 (1997) 2635-2643
36. de Souza-Pinto N.C., Harris C.C., and Bohr V.A. p53 functions in the incorporation step in DNA base excision repair in mouse liver mitochondria. Oncogene 23 (2004) 6559-6568
37. Regula K.M., and Kirshenbaum L.A. p53 activates the mitochondrial death pathway and apoptosis of ventricular myocytes independent of de novo gene transcription. J Mol Cell Cardiol 33 (2001) 1435-1445
38. Vahsen N., Cande C., Briere J.J., Benit P., Joza N., Larochette N., et al. AIF deficiency compromises oxidative phosphorylation. EMBO J 23 (2004) 4679-4689
39. Joza N., Oudit G.Y., Brown D., Benit P., Kassiri Z., Vahsen N., et al. Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy. Mol Cell Biol 25 (2005) 10261-10272
40. Crow M.T., Mani K., Nam Y.J., and Kitsis R.N. The mitochondrial death pathway and cardiac myocyte apoptosis. Circ Res 95 (2004) 957-970
41. Bartunek J., Vanderheyden M., Knaapen M.W., Tack W., Kockx M.M., and Goethals M. Deoxyribonucleic acid damage/repair proteins are elevated in the failing human myocardium due to idiopathic dilated cardiomyopathy. J Am Coll Cardiol 40 (2002) 1097-1103
42. Zhang D., Mott J.L., Farrar P., Ryerse J.S., Chang S.W., Stevens M., et al. Mitochondrial DNA mutations activate the mitochondrial apoptotic pathway and cause dilated cardiomyopathy. Cardiovasc Res 57 (2003) 147-157
43. Mott J.L., Zhang D., Stevens M., Chang S., Denniger G., and Zassenhaus H.P. Oxidative stress is not an obligate mediator of disease provoked by mitochondrial DNA mutations. Mutat Res 474 (2001) 35-45
44. Zhang D., Mott J.L., Chang S.W., Stevens M., Mikolajczak P., and Zassenhaus H.P. Mitochondrial DNA mutations activate programmed cell survival in the mouse heart. Am J Physiol Heart Circ Physiol 288 (2005) H2476-H2483